Innovative Clinical Trial Designs for Drug Development

This technical report reviews the application of innovative clinical trial designs, including platform, enrichment, and adaptive designs, aimed at advancing drug development. It discusses how these designs can facilitate the delivery of new therapies to patients more efficiently. The report highlights the growing importance of genomics and proteomics in understanding diseases, particularly in oncology, where traditional trial methods may be impractical due to patient population segmentation. It outlines regulatory initiatives by agencies such as the FDA and EMA to encourage the adoption of complex trial designs. The report details specific examples of platform trials, including their role in COVID-19 treatment identification, and discusses the concepts of basket and umbrella trials, which assess multiple treatments based on genetic markers. Additionally, it explains enrichment designs that enhance the probability of trial success and adaptive designs that allow for modifications based on real-time data. The report emphasizes the need for intelligent planning and collaboration with regulatory bodies to successfully implement these innovative approaches.